Purchase Order HHSN272201701036P
Award Date 8/22/17
Potential Completion Date 9/11/17
Potential Value $5.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Belmont, CA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Lakepharma, Inc., a minority-owned, for-profit biopharmaceutical contract development and manufacturing organization (CDMO). The $20,000 contract is for the "heavy and light humanization of 1B3 MAB", which involves antibody humanization services to support NIAID's medical research and healthcare mission. The...
- This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Lakepharma, Inc. for $21,769.00 in testing services. The contract has no set-aside designation and was completed on July 3, 2015. Lakepharma, Inc. is a Contract Development and Manufacturing Organization (CDMO) that provides pharmaceutical and biotech services, including affinity maturation, production of...
- This is a $5,545.00 firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Lakepharma, Inc., a minority-owned and Asian-Pacific American-owned for-profit organization. The contract is for custom antibody and protein purification services to be performed in Belmont, CA. Lakepharma, Inc. is a contract development and manufacturing organization (CDMO) that has previously...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $3,799.00 firm-fixed-price purchase order contract to Lakepharma, Inc., a minority-owned, for-profit, Asian-Pacific American-owned business, for the cloning and sequencing of mouse hybridoma. The contract has a completion date of September 29, 2017 and was awarded on August 2, 2017. Lakepharma, Inc. is a Contract Development and Manufacturing Organization...
- This is a $6,891.78 firm fixed-price purchase order awarded by the National Institute of Mental Health (NIMH) to Lakepharma, Inc., a minority-owned, for-profit contract development and manufacturing organization (CDMO). The contract is for expression optimization and immunoaffinity capture (IMAC) pulldown services to support NIMH's internal research. The contract has a period of performance through September 9, 2025. There was no set-aside used for this award. Lakepharma has previously...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $10,580.00 firm fixed-price purchase order to Lofstrand Labs LTD, a for-profit limited liability company, for antibody production and purification services. The contract does not have a set-aside designation and has an ultimate completion date of May 26, 2017. Lofstrand Labs LTD is the prime contractor, and no subcontractors are mentioned. The award is not associated with a larger contract vehicle...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $210,338.00 firm fixed-price purchase order to Creative Biolabs Inc. for mouse antibody production services across Phases I through IV. The contract, which runs through September 22, 2025, does not have a set-aside designation. Creative Biolabs, a specialized biotechnology and pharmaceutical services provider, will deliver custom solutions in...
- This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, Maryland. The $31,435.00 contract is for the production of 20 liters of monoclonal antibodies at $1,500 per liter. This award supports NIAID's infectious disease research efforts, leveraging Geneimmune's expertise in areas such as gene...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $49,946.10 firm-fixed-price purchase order contract for antibody expression services to Biointron Biological USA Inc., a small disadvantaged business. The contract, which has no set-aside designation, has an ultimate completion date of July 11, 2025. The award was made on July 12, 2024. NIAID is responsible for conducting and supporting research to understand, treat, and prevent infectious and...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The award, valued at $14,994, is for the delivery of 5,400 crude peptides by A & A LABS LLC, also doing business as Synthetic Biomolecules. The contract does not have a set-aside designation. A & A LABS LLC is a minority-owned, small disadvantaged business. This contract award may support NIAID's...